Incyte Corporation (Nasdaq: INCY) announced today that it has scheduled
its fourth quarter/year-end 2012 financial results conference call for
8:30 a.m. ET on Thursday, February 14, 2013. The schedules for the press
release and conference call are as follows:
|
|
|
|
|
|
|
-- Q4 & YE 2012 Press Release:
|
|
|
|
February 14, 2013 at 7:00 a.m. ET
|
|
-- Q4 & YE 2012 Conference Call:
|
|
|
|
February 14, 2013 at 8:30 a.m. ET
|
|
-- Domestic Dial In Number:
|
|
|
|
877-407-8037
|
|
-- International Dial In Number:
|
|
|
|
201-689-8037
|
|
-- Conference ID #
|
|
|
|
407848
|
|
|
|
|
|
|
If you are unable to participate, a replay of the conference call will
be available for thirty days. The replay dial-in number for the U.S. is
877-660-6853 and dial-in number for international callers is
201-612-7415. To access the replay you will need the conference ID
number 407848.
The conference call will also be webcast live and can be accessed at www.incyte.com
under Investor Relations, Events and Webcasts.
About Incyte
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical
company focused on the discovery, development and commercialization of
proprietary small molecule drugs for oncology and inflammation. For
additional information on Incyte, please visit the Company's web site at www.incyte.com.
